期刊文献+

肾移植术后人巨细胞病毒感染的诊断 被引量:1

The diagnosis of cytomegalovirus infection after renal transplantation
下载PDF
导出
摘要 目前肾移植术已较为成熟,在经历了手术技术、宿主对异体器官排斥反应的困难之后,大量免疫抑制剂应用所诱发的感染已成为器官移植患者的重要并发症和死亡原因,其中人巨细胞病毒(human cytomegalovirus,HCMV)感染,起病急,发展快,易出现多脏器功能衰竭。国外报道,肾移植术后HCMV感染率为59%~79%,HCMV感染发生率为38.4%,HCMV感染相关死亡人数占肾移植近期总死亡人数的2%。HCMV感染的早期诊断可提高移植器官存活率,降低病死率。本文就HCMV感染的早期诊断方法做一简要综述。
出处 《中国感染与化疗杂志》 CAS 2006年第6期424-427,共4页 Chinese Journal of Infection and Chemotherapy
基金 北京市中医局-中西医结合诊治肾移植术后肺炎的临床研究(Ⅰ-13)
  • 相关文献

参考文献19

  • 1Schroeder R,Michelon T,Fagundes I,et al.Antigenemia for cytomegalovirus in renal transplantation:choosing a cut-off for the diagnosis criteria in cytomegalovirus disease[J].Transplant Proc,2005,37:2781-2783.
  • 2Gleaves CA,Sminth TF,Shuster EA,et al.Comparison of standard tube and shell vial cell culture techniques for the detectiono cytomegalovirus in clinical specimens[J].J Clin Microbiol,1985,21:217-221.
  • 3方峰,陈静,聂兴草,董永绥,崔雯.人巨细胞病毒短时培养快速诊断改良技术的建立及其应用[J].中华儿科杂志,2002,40(7):395-397. 被引量:15
  • 4Slavicek J,Puretic Z,Glavas-Boras S,et al.Primary cytomegalovirus infection after combined cadaveric transplantation of the liver and kidney[J].Acta Med Croatica,2003,57:87-90.
  • 5Gerna G,Revello MG,Perci valle E,et al.Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia[J].J Clin Microbiol,1992,30:1232-1237.
  • 6Ghisetti V,Barbui A,Rocci MP,et al.Detection of human cytomegalovirus myocardial involvement by polymerase chain reaction during systemic infection and correlation with pp65antigenemia and DNAemia in infected heart recipients[J].Transplantation,1996,61:1072-1075.
  • 7Razonable RR,Paya CV,Smith TF.Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients[J].J Clin Microbiol,2002,40:746-752.
  • 8Wattal C,Joshi S,Gupta A,et al.The PP67 mRNA assay in treatment and monitoring of cytomegalovirus disease in renal transplant patients in India[J].Transpl Infect Dis,2004,6:90-92.
  • 9赵缜,孙洪斌,彭奕冰,季育华.检测pp65抗原和IgM抗体对移植患者CMV活动性感染监测价值比较[J].临床检验杂志,2004,22(4):278-279. 被引量:12
  • 10Gouarin S,Vabret A,Gault E,et al.Quantitative analysis of HCMV DNA load in whole blood of renal transplant patients using real-time PCR assay.[J].Clin Virol,2004,29:194-201.

二级参考文献8

  • 1张仕光,吴培根,纪玉莲,史伟,陈文岩.肾移植患者巨细胞病毒感染[J].中华器官移植杂志,1996,17(2):88-88. 被引量:6
  • 2叶任高,临床肾脏病学,1997年,318页
  • 3Homef M W, Hackstein H, Kirchner H, et al. Significance of cytoplasmic staining in the cytomegalovirus pp65 antigen test[ J ]. Eur J Clin Microbiol Infect Dis, 1999,18( 1 ) :66-68.
  • 4Singh N, Paterson D L, Gayowski T, et al. Cytomegalovirus antigenemia directed pre-emptive prophylaxis with oral versus I. V.ganciclovir for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized controlled trial [ J ].Transplantation, 2000, 70 ( 5 ): 717-722.
  • 5Sia I G, Patel R. New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients[ J]. Clin Microbiol Rev, 2000, 13 (1): 83-121.
  • 6方峰,董永绥.巨细胞病毒和巨细胞病毒感染的诊断[J].中华儿科杂志,1999,37(7):397-399. 被引量:177
  • 7赵缜.移植病人中HCMV激活感染标志的研究进展[J].国外医学(病毒学分册),2001,8(6):180-182. 被引量:6
  • 8夏吉荣,王富兰,祝继华.人巨细胞病毒活动性感染的分析[J].重庆医科大学学报,2003,28(2):195-197. 被引量:7

共引文献33

同被引文献19

  • 1王振迪,李恒,曾甫清.肾移植术后巨细胞病毒感染的诊治体会[J].临床外科杂志,2007,15(2):100-101. 被引量:4
  • 2李薇,谢闻悦,陈永强,刘俊,张璇.应用间接免疫荧光技术检测人巨细胞病毒-PP65抗原的临床意义[J].实用医学杂志,2007,23(9):1398-1400. 被引量:13
  • 3郭乃榄 陆道培 等.大蒜提取物体外抑制巨细胞病毒的研究[J].中华实验和临床病毒学杂志,1991,5:58-60.
  • 4Sageda S,Nordal KP,Hartmann A,et al.The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients.Am J Transplant.2002;2(9):85.
  • 5Hibberd PL,Tolkoff-Rubin NE,Conti D,et al.Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients.A randomized controlled trial.Ann Intem Med.1995;123(1):18.
  • 6Peterson PK,Balfour HH Jr,Marker SC,et al.Cytomegalovirus disease in renal allograft recipients:a prospective study of the clinical features,risk factors and impact on renal transplantation.Medicine(Baltimore).1980;59(4):283.
  • 7El-Faramawi M,Rohr N,Jespersen B.Steroid-free immunosuppression after renal transplantation-long-term experience from a single centre.Nephrol Dial Transplant.2006;21(7):1966-1973.
  • 8Nassetta L,Kimberiin D,Whitley R.Treatment of congenital cytomegalovirus infectiomimplications for futre therapeutic strategies.J Antimicrob.2009;63(5):862-867.
  • 9Trofe J,Pote L,Wade E,et al.Maribavir:A Novel Antiviral Agent with Activity Against Cytomegalovirus.Ann Pharmacother.2008;42(10):1447-1457.
  • 10Davies NM,Grinyo J,Heading R,et al.Gastrointestinal side effects of mycophenolic acid in renal transplant patients:a reappraisal.Nephrol Dial Transplant.2007:22(9):2440-2448.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部